Literature DB >> 14742261

Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis.

David Hedley1, Melania Pintilie, Jennifer Woo, Trudey Nicklee, Andrew Morrison, Diana Birle, Anthony Fyles, Michael Milosevic, Richard Hill.   

Abstract

Thioredoxin and apurinic/apyrimidinic excision (APE)/ref-1 are important redox mediators in biochemical pathways that promote cell survival under adverse conditions including hypoxia and oxidative stress. For example, elevated levels occur surrounding vascular infarcts and protect from reperfusion injury. Because elevated thioredoxin or APE/ref-1 is also associated with resistance to certain forms of cancer treatment, we examined their tissue distribution in a series of 110 cervical carcinoma biopsies. Analysis was done using a quadruple fluorescence imaging technique, incorporating carbonic anhydrase IX (CAIX) immunofluorescence to outline hypoxic microregions and 4',6-diamidino-2-phenylindole to localize nuclear staining of thioredoxin and APE/ref-1. A scanning autostage was used to image the entire tissue section. Thioredoxin and APE/ref-1 levels were expressed as the average pixel brightness in tumor tissue, subdivided based on CAIX and 4',6-diamidino-2-phenylindole staining. Results showed that the nuclear and cytoplasmic levels of thioredoxin were similar, whereas APE/ref-1 expression was greater in nuclei. Neither of these markers was predictive of outcome in this series of patients treated with radical radiotherapy. Both proteins showed highly significant elevations in CAIX-positive regions compared to CAIX-negative regions, and there was a nonsignificant trend for this effect to be greater in adenocarcinomas compared to squamous cell carcinomas. Levels of APE/ref-1 decreased with increasing tumor grade, but the expression was similar in CAIX-positive regions of poorly differentiated tumors compared to moderately or well-differentiated tumors. Elevated expression of thioredoxin and APE/ref-1 might promote cancer cell survival in hypoxic microenvironments of cervical carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742261      PMCID: PMC1602260          DOI: 10.1016/S0002-9440(10)63145-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

Review 1.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Authors:  C C Wykoff; N J Beasley; P H Watson; K J Turner; J Pastorek; A Sibtain; G D Wilson; H Turley; K L Talks; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 3.  From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins.

Authors:  L H Butterfield; A Merino; S H Golub; H Shau
Journal:  Antioxid Redox Signal       Date:  1999       Impact factor: 8.401

4.  Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.

Authors:  M Ema; K Hirota; J Mimura; H Abe; J Yodoi; K Sogawa; L Poellinger; Y Fujii-Kuriyama
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

Review 5.  Antioxidant function of thioredoxin and glutaredoxin systems.

Authors:  A Holmgren
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

Review 6.  Physiological functions of thioredoxin and thioredoxin reductase.

Authors:  E S Arnér; A Holmgren
Journal:  Eur J Biochem       Date:  2000-10

Review 7.  Going APE over ref-1.

Authors:  A R Evans; M Limp-Foster; M R Kelley
Journal:  Mutat Res       Date:  2000-10-16       Impact factor: 2.433

8.  Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.

Authors:  D H Moore; H Michael; R Tritt; S H Parsons; M R Kelley
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

Review 9.  Microenvironment-induced cancer metastasis.

Authors:  E K Rofstad
Journal:  Int J Radiat Biol       Date:  2000-05       Impact factor: 2.694

10.  Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.

Authors:  E K Rofstad; K Sundfør; H Lyng; C G Tropé
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

View more
  10 in total

1.  A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Authors:  A Mukherjee; K Huber; H Evans; N Lakhani; S Martin
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

2.  Expression profile of genes coding for DNA repair in human oocytes using pangenomic microarrays, with a special focus on ROS linked decays.

Authors:  Yves Menezo; GianLuigi Russo; Elisabetta Tosti; Said El Mouatassim; Moncef Benkhalifa
Journal:  J Assist Reprod Genet       Date:  2007-09-27       Impact factor: 3.412

3.  Quantitative image analysis of immunohistochemical stains using a CMYK color model.

Authors:  Nhu-An Pham; Andrew Morrison; Joerg Schwock; Sarit Aviel-Ronen; Vladimir Iakovlev; Ming-Sound Tsao; James Ho; David W Hedley
Journal:  Diagn Pathol       Date:  2007-02-27       Impact factor: 2.644

Review 4.  Oxidative stress and HPV carcinogenesis.

Authors:  Federico De Marco
Journal:  Viruses       Date:  2013-02-12       Impact factor: 5.048

5.  PX-12-induced HeLa cell death is associated with oxidative stress and GSH depletion.

Authors:  Hye Rim Shin; Bo Ra You; Woo Hyun Park
Journal:  Oncol Lett       Date:  2013-10-21       Impact factor: 2.967

6.  Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation.

Authors:  Therese Christina Karlenius; Kathryn Fay Tonissen
Journal:  Cancers (Basel)       Date:  2010-03-25       Impact factor: 6.639

7.  Development of pathological diagnostics of human kidney cancer by multiple staining using new fluorescent Fluolid dyes.

Authors:  Dilibaier Wuxiuer; Yun Zhu; Takunori Ogaeri; Keiji Mizuki; Yuki Kashiwa; Kentaro Nishi; Shin-ichiro Isobe; Tei-ichiro Aoyagi; Ryoiti Kiyama
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

8.  Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.

Authors:  P J Boström; J Thoms; J Sykes; O Ahmed; A Evans; B W G van Rhijn; T Mirtti; O Stakhovskyi; M Laato; D Margel; M Pintilie; C Kuk; M Milosevic; A R Zlotta; R G Bristow
Journal:  Bladder Cancer       Date:  2016-01-07

9.  Proteomics Analysis Revealed that Crosstalk between Helicobacter pylori and Streptococcus mitis May Enhance Bacterial Survival and Reduces Carcinogenesis.

Authors:  Yalda Khosravi; Mun Fai Loke; Khean Lee Goh; Jamuna Vadivelu
Journal:  Front Microbiol       Date:  2016-09-15       Impact factor: 5.640

10.  Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells.

Authors:  Bodo Haas; Lena Schütte; Maria Wos-Maganga; Sandra Weickhardt; Marco Timmer; Niels Eckstein
Journal:  Int J Mol Sci       Date:  2018-09-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.